TORONTO, April 26, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (Cronos or the Company) will hold its 2024 Annual Meeting of Shareholders on Thursday, June 20, 2024, at...
TORONTO, April 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (Cronos or the Company) will hold its 2024 first quarter earnings conference call on Thursday, May 9,...
TORONTO, March 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (Cronos or the Company), an innovative global cannabinoid company, announced today the launch of Lord...
Cronos Group Inc. to Speak at the 36th Annual Roth Conference
Cronos Group Reports 2023 Fourth Quarter and Full-Year Results¹
TORONTO, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (œCronos or the œCompany) will hold its 2023 fourth quarter and full-year earnings conference call on...
TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (œCronos or the œCompany), an innovative global cannabinoid company, today announced that its brand,...
TORONTO, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (œCronos or the œCompany) announced today that it is expanding distribution into the Australian market with...
TORONTO, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (œCronos or the œCompany) is proud to announce the launch of its highly anticipated Lord Jones® Live Resin...
TORONTO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (œCronos or the œCompany) today announced that its wholly owned subsidiary entered into an agreement (the...